ClinConnect ClinConnect Logo
Search / Trial NCT05714189

The Effect of Dietary Interventions, or no Intervention, on Pain and Quality of Life in Women Diagnosed With Endometriosis

Launched by AMSTERDAM UMC, LOCATION VUMC · Jan 26, 2023

Trial Information

Current as of April 28, 2025

Completed

Keywords

ClinConnect Summary

This prospective pilot study was performed to explore the influence of a dietary intervention, the Low FODMAP diet or endometriosis diet, on endometriosis-related pain and Quality of Life (QoL). Participants could choose between adherence to a diet; the Low FODMAP diet or endometriosis diet, or to contribute to the control group and not adhere to a diet. Women choosing to adhere to a diet were extensively guided by a dietician in training. In addition, both groups are asked to complete three questionnaires over a period of six months; once every two months.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women diagnosed with endometriosis, either through radiologic imaging (transvaginal ultrasound and/or MRI) or laparoscopy
  • A reported pain score of ≥ 3 (Visual Analogue Score (VAS), scale 0-10cm) in one or more of the following symptoms: dysmenorrhea, deep dyspareunia and chronic pelvic pain
  • Exclusion Criteria:
  • about to undergo an operation within six months
  • Undergone an operation in the past six weeks
  • a switch in hormonal therapy within six weeks
  • Women that were pregnant or breastfeeding
  • women diagnosed with a malignancy
  • An additional diagnosis with Coeliac Disease (CD) and/or lactose intolerance.
  • Not sufficient in the Dutch or English language.

About Amsterdam Umc, Location Vumc

Amsterdam UMC, located at VU Medical Center (VUmc), is a leading academic medical center in the Netherlands dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on translating scientific discoveries into practical applications, Amsterdam UMC collaborates closely with researchers, healthcare professionals, and industry partners to enhance patient outcomes. The institution is committed to rigorous ethical standards and regulatory compliance, ensuring the integrity and reliability of its clinical research initiatives across various medical disciplines.

Locations

Amsterdam, , Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials